Binocrit

 

Topic mentions per year

Topic mentions per year

2008-2016
012320082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Comprehensive physicochemical characterization and biological assays are essential parts in assessing quality attributes of… (More)
Is this relevant?
2014
2014
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders characterized by bone marrow failure and a risk… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2013
2013
  • Drug and therapeutics bulletin
  • 2013
All prescribers will be familiar with the issues associated with the use of branded and generic 'chemical' medicines.(1) For… (More)
Is this relevant?
2012
2012
AIM To evaluate the effectiveness of a biosimilar erythropoiesis-stimulating agent (Binocrit) for the treatment of patients with… (More)
Is this relevant?
2012
2012
The aim of this study was to develop an integrated pharmacokinetic and pharmacodynamic (PK/PD) model and assess the comparability… (More)
  • figure 1
  • figure 2
  • table II
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Background:HX575, licensed under the brand names Binocrit , Epoetin Alfa Hexal , and Abseamed , was approved in 2007 as the first… (More)
  • figure 1
  • table I
  • figure 2
  • table II
  • table III
Is this relevant?
Review
2011
Review
2011
zeta, administered intravenously, for maintenance treatment of renal anemia. Adv Ther. 2008;25(11):1215-28. 12. Krivoshiev S… (More)
  • table 1
  • table 2
Is this relevant?
2010
2010
To compare the quality of therapeutic erythropoietin (EPO) products, including two biosimilars, with respect to content… (More)
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
This year will see the first serious engagements in the biogenerics war, as two copycat versions of the world’s biggest-selling… (More)
  • table 1
Is this relevant?